Literature DB >> 16912478

Serial measurements of N-terminal pro-brain natriuretic peptide after acute ischemic stroke.

J K Jensen1, H Mickley, S Bak, L Korsholm, S R Kristensen.   

Abstract

BACKGROUND: The exact time-course of N-terminal pro-brain natriuretic peptide (NT-proBNP) and the prognostic importance in the immediate phase of ischemic stroke have not been established.
METHODS: NT-proBNP was measured daily from admission to day 5 and again at 6-month follow-up in 250 consecutive patients with acute ischemic stroke.
RESULTS: NT-proBNP peaked the day after onset of symptoms (p = 0.007) followed by a decrease until day 5 (p = 0.001, ANOVA). At 6-month follow-up the difference in the level of NT-proBNP was unchanged compared to day 5 (p = 0.42). NT-proBNP levels > or =615 pg/ml at day 2 after onset of symptoms was associated with 6-month mortality.
CONCLUSION: NT-proBNP peaks the day after onset of symptoms in patients with acute ischemic stroke. A single measurement of NT-proBNP appears to be an indicator of 6-month mortality. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912478     DOI: 10.1159/000094997

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  6 in total

1.  The role of N-terminal pro-brain natriuretic peptide in evaluating the prognosis of patients with intracerebral hemorrhage.

Authors:  Fei Li; Qian-Xue Chen; Shou-Gui Xiang; Shi-Zhun Yuan; Xi-Zhen Xu
Journal:  J Neurol       Date:  2017-08-24       Impact factor: 4.849

2.  Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy.

Authors:  W T Longstreth; Richard A Kronmal; John L P Thompson; Robert H Christenson; Steven R Levine; Rebecca Gross; Robin L Brey; Richard Buchsbaum; Mitchell S V Elkind; David L Tirschwell; Stephen L Seliger; J P Mohr; Christopher R deFilippi
Journal:  Stroke       Date:  2013-01-22       Impact factor: 7.914

3.  Plasmatic B-type natriuretic peptide and C-reactive protein in hyperacute stroke as markers of CT-evidence of brain edema.

Authors:  Pedro J Modrego; Beatriz Boned; Juan J Berlanga; Mercedes Serrano
Journal:  Int J Med Sci       Date:  2008-01-13       Impact factor: 3.738

4.  Markers of endothelial pathology to support detection of atrial fibrillation in embolic stroke of undetermined source.

Authors:  Nora L Ziegler; Jan-Thorben Sieweke; Saskia Biber; Maria M Gabriel; Ramona Schuppner; Hans Worthmann; Jens Martens-Lobenhoffer; Ralf Lichtinghagen; Stefanie M Bode-Böger; Udo Bavendiek; Karin Weissenborn; Gerrit M Grosse
Journal:  Sci Rep       Date:  2019-12-19       Impact factor: 4.379

5.  Prevalence and determinants of systolic and diastolic cardiac dysfunction and heart failure in acute ischemic stroke patients: The SICFAIL study.

Authors:  Peter U Heuschmann; Felipe A Montellano; Kathrin Ungethüm; Viktoria Rücker; Silke Wiedmann; Daniel Mackenrodt; Anika Quilitzsch; Timo Ludwig; Peter Kraft; Judith Albert; Caroline Morbach; Stefan Frantz; Stefan Störk; Karl Georg Haeusler; Christoph Kleinschnitz
Journal:  ESC Heart Fail       Date:  2020-12-22

Review 6.  B-type natriuretic peptides and mortality after stroke: a systematic review and meta-analysis.

Authors:  Teresa García-Berrocoso; Dolors Giralt; Alejandro Bustamante; Thorleif Etgen; Jesper K Jensen; Jagdish C Sharma; Kensaku Shibazaki; Ayhan Saritas; Xingyong Chen; William N Whiteley; Joan Montaner
Journal:  Neurology       Date:  2013-11-01       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.